Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.25.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Revenues $ 24,268 $ 20,876 $ 6,026
Cost of revenues (25,429) (32,490) (14,790)
Gross loss (1,161) (11,614) (8,764)
Operating expenses:      
Research and development 73,817 92,676 95,107
Sales and marketing 7,474 8,777 10,300
General and administrative 19,466 19,535 19,178
Total operating expenses 100,757 120,988 124,585
Operating loss (101,918) (132,602) (133,349)
Financial income, net 7,328 9,790 6,802
Loss before taxes on income (94,590) (122,812) (126,547)
Taxes on income (167) (642) (325)
Net loss $ (94,757) $ (123,454) $ (126,872)
Basic net loss per ordinary share $ (0.57) $ (0.84) $ (0.94)
Diluted net loss per ordinary share $ (0.57) $ (0.84) $ (0.94)
Weighted average number of ordinary shares used in computing basic net loss per ordinary share 167,216,070 147,480,521 135,224,312
Weighted average number of ordinary shares used in computing diluted net loss per ordinary share 167,216,070 147,480,521 135,224,312